Crossbow Therapeutics, Inc.
Cambridge, MA · also filed as None
What changed
$30M raise filed (Form D)
9mo agoRaise filed (Form D)Sep 30, 2025Source filing (opens the source filing in a new tab)
Momentum
Momentum 40 out of 100, unchanged since the last recompute.
Some recent activity, at a steady rate.
Runway (estimate)
The last disclosed raise still models out past a year.
Stage
Formed
The furthest-along thing in the public record. Not a projection.
Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.
Grant to raise
Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.
- Filing
Form D · $30M
Sep 30, 2025Crossbow Therapeutics, Inc. · private raise, self-reported by the issuer
SEC EDGAR · 0000905148-25-003444 (opens the source filing in a new tab)
Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources